MHRP expanded its Multinational Observational Cohort Study of HIV and Other Infections (MOCHI) to Nigeria in June through a partnership with the Nigerian Ministry of Defence Health Implementation Programme (MOD HIP).
MHRP, in collaboration with the Armed Forces of the Philippines (AFP) and other partners, is conducting a study to characterize HIV-1 viruses that are currently circulating in the Philippines.
Under the DELIVER initiative, MHRP researchers are conducting targeted technology transfer to expand HIV cure research capacity. Early efforts focus on transferring neutralization, pharmacokinetic (PK), and anti-drug antibody (ADA) assays to DELIVER partner sites, beginning in Tanzania and Thailand. By decentralizing these processes, DELIVER is strengthening local research infrastructure and advancing HIV research capabilities at a network of sites through Africa, Asia and South America.
An ongoing Phase 1 human trial in Tanzania is evaluating the safety and antiviral activity of a novel bispecific antibody, alone and in combination with another potent monoclonal antibody, to combat HIV.
Mentor Mothers, like Sarah Mwakajinga, play a vital role in the Prevention of Mother-to-Child Transmission (PMTCT) program. Sarah was introduced to Salome early in her journey and has been by her side ever since.
